APOE and Alzheimer disease: ApoE4-enhanced metabolic changes and neuroinflammation via amyloid toxicity, tau toxicity, mitochondrial dysfunction, mitophagy, and insulin resistance may contribute to neurodegenerative changes in AD [72,73].